Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriko Nishimura

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Toxicology and Applied Pharmacology|July 9, 2008
Critical role of cyclooxygenase-2 activation in pathogenesis of hydronephrosis caused by lactational exposure of mice to dioxinNoriko Nishimura, Fumio Matsumura, Christopher F A Vogel, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2016
Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional TranslocationYasuyuki Shigematsu, Motoki Matsuura, Noriko Nishimura, et al.
Oncogene|June 25, 2003
Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4cNoriko Nishimura, Yusuke Furukawa, Krittaya Sutheesophon, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 18, 2005
[Assessment of immunotoxicity of irinotecan determined by the novel method, by which productivity of TNF-alpha from whole blood is stimulated by lipopolysaccharide]Yusai Kawaguchi, Hiroshi Araki, Akihiko Nakagawa, et al.
Leukemia & Lymphoma|December 11, 2012
Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapyKyoko Ueda, Yasuhito Terui, Masahiro Yokoyama, et al.
BMC Cancer|April 7, 2021
Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)Masahiro Yokoyama, Yoshiharu Kusano, Norihito Inoue, et al.
American Journal of Physiology. Renal Physiology|July 22, 2016
Polyuria-associated hydronephrosis induced by xenobiotic chemical exposure in miceWataru Yoshioka, Tatsuya Kawaguchi, Noriko Nishimura, et al.
Anticancer Research|July 3, 2019
Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial CancerShotaro Yasuoka, Takeshi Yuasa, Noriko Nishimura, et al.
Journal of Cellular Physiology|October 30, 2004
Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228)Krittaya Sutheesophon, Noriko Nishimura, Yukiko Kobayashi, et al.
Leukemia Research|August 12, 2020
MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab eraNoriko Nishimura, Kengo Takeuchi, Reimi Asaka, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Toxicology and Applied Pharmacology|July 9, 2008
Critical role of cyclooxygenase-2 activation in pathogenesis of hydronephrosis caused by lactational exposure of mice to dioxinNoriko Nishimura, Fumio Matsumura, Christopher F A Vogel, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2016
Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional TranslocationYasuyuki Shigematsu, Motoki Matsuura, Noriko Nishimura, et al.
Oncogene|June 25, 2003
Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4cNoriko Nishimura, Yusuke Furukawa, Krittaya Sutheesophon, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 18, 2005
[Assessment of immunotoxicity of irinotecan determined by the novel method, by which productivity of TNF-alpha from whole blood is stimulated by lipopolysaccharide]Yusai Kawaguchi, Hiroshi Araki, Akihiko Nakagawa, et al.
Leukemia & Lymphoma|December 11, 2012
Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapyKyoko Ueda, Yasuhito Terui, Masahiro Yokoyama, et al.
BMC Cancer|April 7, 2021
Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)Masahiro Yokoyama, Yoshiharu Kusano, Norihito Inoue, et al.
American Journal of Physiology. Renal Physiology|July 22, 2016
Polyuria-associated hydronephrosis induced by xenobiotic chemical exposure in miceWataru Yoshioka, Tatsuya Kawaguchi, Noriko Nishimura, et al.
Anticancer Research|July 3, 2019
Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial CancerShotaro Yasuoka, Takeshi Yuasa, Noriko Nishimura, et al.
Journal of Cellular Physiology|October 30, 2004
Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228)Krittaya Sutheesophon, Noriko Nishimura, Yukiko Kobayashi, et al.
Leukemia Research|August 12, 2020
MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab eraNoriko Nishimura, Kengo Takeuchi, Reimi Asaka, et al.
Pageof 9